TotalMarketCap

Arbutus Biopharma

ABUSNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$561.756 M

$3.67 -9.73%

Close of 6 Nov 2026

As of 6 Nov 2026, Arbutus Biopharma (ABUS) has a market capitalization of $561.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$14.1M

#3061 by revenue

Earnings

-$33.5M

Loss-making

Shares outstanding

197,847,835

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #179Olema PharmaceuticalsOLMA$593.7M
  2. #180ApnimedAPMD$589.1M
  3. #181Arbutus BiopharmaABUS$561.8M
  4. #182Bicara TherapeuticsBCAX$542.6M
  5. #183Aclaris TherapeuticsACRS$529.9M

What if Arbutus Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$184,222.52

Per share 50,265× higher

Bitcoin $1.53T

$9,967.96

Per share 2,720× higher

Apple $5.02T

$32,723.88

Per share 8,929× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Arbutus Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.